Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary Report
Sarah Frey(Johns Hopkins University), Pali D. Shah(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Joby Matthew, Jessica M. Ruck(Johns Hopkins University), Jennifer L. Alejo(Johns Hopkins University), Robin K. Avery(Johns Hopkins University), Lindsay Barker(Johns Hopkins Hospital), Dorry L. Segev(New York University)
Cited by 5
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686